Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (71-80 of 1,137) with videos related to

Pageof 114
Sort By:
Critical Pathways in Cardiology|March 15, 2008
What is the optimal timing of clopidogrel in acute coronary syndromes?Christopher P Cannon
Critical Pathways in Cardiology|March 15, 2008
Implementation of critical pathways in the "real world"Christopher P Cannon
Critical Pathways in Cardiology|March 15, 2008
Critical pathway for unstable angina and non-ST elevation myocardial infarction: February 2002Christopher P Cannon
Critical Pathways in Cardiology|March 15, 2008
Palm Pilot programs to improve quality of care in acute coronary syndromesChristopher P Cannon
The American Journal of Cardiology|August 2, 2007
Introduction: rationale for tight control of hyperglycemiaChristopher P Cannon
Evidence-Based Cardiovascular Medicine|December 29, 2005
Reteplase was not better than alteplase in reducing 30-day mortality among patients with acute MIC P Cannon
Evidence-Based Cardiovascular Medicine|December 29, 2005
Double-bolus alteplase was not equivalent to accelerated infusion in patients with acute MIC P Cannon
The American Journal of Cardiology|December 17, 2008
Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implicationsChristopher P Cannon
Clinical Cornerstone|October 20, 2007
High-density lipoprotein cholesterol and residual cardiometabolic risk in metabolic syndromeChristopher P Cannon
Critical Pathways in Cardiology|December 4, 2008
Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) ST-segment elevation myocardial infarction critical pathway toolkitChristopher P Cannon,
Pageof 114

Showing results (71-80 of 1,137) with videos related to

Sort By:
Pageof 114
Critical Pathways in Cardiology|March 15, 2008
What is the optimal timing of clopidogrel in acute coronary syndromes?Christopher P Cannon
Critical Pathways in Cardiology|March 15, 2008
Implementation of critical pathways in the "real world"Christopher P Cannon
Critical Pathways in Cardiology|March 15, 2008
Critical pathway for unstable angina and non-ST elevation myocardial infarction: February 2002Christopher P Cannon
Critical Pathways in Cardiology|March 15, 2008
Palm Pilot programs to improve quality of care in acute coronary syndromesChristopher P Cannon
The American Journal of Cardiology|August 2, 2007
Introduction: rationale for tight control of hyperglycemiaChristopher P Cannon
Evidence-Based Cardiovascular Medicine|December 29, 2005
Reteplase was not better than alteplase in reducing 30-day mortality among patients with acute MIC P Cannon
Evidence-Based Cardiovascular Medicine|December 29, 2005
Double-bolus alteplase was not equivalent to accelerated infusion in patients with acute MIC P Cannon
The American Journal of Cardiology|December 17, 2008
Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implicationsChristopher P Cannon
Clinical Cornerstone|October 20, 2007
High-density lipoprotein cholesterol and residual cardiometabolic risk in metabolic syndromeChristopher P Cannon
Critical Pathways in Cardiology|December 4, 2008
Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) ST-segment elevation myocardial infarction critical pathway toolkitChristopher P Cannon,
Pageof 114